{"id":"procaterol-salbultamol","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Tremors"},{"rate":"5-10%","effect":"Nervousness"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Palpitations"},{"rate":"5-10%","effect":"Dizziness"}]},"_chembl":{"chemblId":"CHEMBL1322218","moleculeType":"Small molecule","molecularWeight":"326.82"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Procaterol and Salbutamol work by stimulating the beta-2 adrenergic receptors in the lungs, leading to bronchodilation and relief of bronchospasm. This results in improved lung function and symptoms in patients with asthma and chronic obstructive pulmonary disease (COPD).","oneSentence":"Procaterol is a beta-2 adrenergic receptor agonist, and Salbutamol is a beta-2 adrenergic receptor agonist.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:30:12.173Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Asthma"},{"name":"Chronic obstructive pulmonary disease (COPD)"}]},"trialDetails":[{"nctId":"NCT00990847","phase":"PHASE3","title":"Nebulized Procaterol Versus Nebule Salbutamol for the Treatment of Moderate Acute Asthma","status":"COMPLETED","sponsor":"PT Otsuka Indonesia","startDate":"2007-06","conditions":"Moderate Acute Asthma","enrollment":140}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Procaterol, Salbultamol","genericName":"Procaterol, Salbultamol","companyName":"PT Otsuka Indonesia","companyId":"pt-otsuka-indonesia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Procaterol and Salbutamol are small molecule medications used to treat moderate acute asthma. They are administered via nebulization, with Procaterol being compared to Salbutamol in clinical trials for their efficacy in treating moderate acute asthma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}